QT
ITCI

Quantamental Technologies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quantamental Technologies’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,805
Closed -$49K – 1877
2019
Q2 		$49K Buy
+3,805
New +$48.8K 0.02% 910

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantamental Technologies's ITCI Position: Q3 2019 in Review

Quantamental Technologies sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2019, closing a stake of 3,805 shares — an estimated $49K sold.

Quantamental Technologies first reported a position in ITCI in Q2 2019 and held it in 1 quarter. The position peaked at $49K in Q2 2019. 126 funds tracked by Wall St. Rank hold ITCI as of Q3 2019.

  • Quantamental Technologies reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,805 Intra-Cellular Therapies Inc. shares in Q3 2019, an estimated $49K.
  • Quantamental Technologies first reported a position in Intra-Cellular Therapies Inc. in Q2 2019 and held it in 1 quarter.
  • Quantamental Technologies's Intra-Cellular Therapies Inc. position peaked at $49K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.